-
Haemonetics Hits 52-Week High (HAE)
Monday, April 11, 2011 - 10:53am | 32Haemonetics (NYSE: HAE) has hit a 52-week high in today's trading. At last check the year-to-date performance of Haemonetics has been a gain of 6.6%.
-
OraSure Technologies Hits 52-Week High (OSUR)
Friday, April 8, 2011 - 11:46am | 33OraSure Technologies (NASDAQ: OSUR) has hit a 52-week high in today's trading. At last check the year-to-date performance of OraSure has been a gain of 46.4%.
-
Alcon Shareholders Approve Merger with Novartis (ACL)
Thursday, April 7, 2011 - 4:17pm | 91Alcon, Inc. (NYSE: ACL) announced that its shareholders approved the merger of Alcon into Novartis AG at its Annual General Meeting of Shareholders. Under the terms of the merger, Alcon shareholders will receive 2.9228 Novartis shares or American Depositary Shares plus a cash payment of $8.20 for...
-
Rochester Medical Completes Acquisition of Laprolan
Thursday, April 7, 2011 - 12:29pm | 56Rochester Medical Corporation (NASDAQ: ROCM) today announced that it has now completed the previously announced purchase of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed...
-
Benzinga's Volume Movers (XNPT, BBBY, BLUD, IMGN)
Thursday, April 7, 2011 - 10:19am | 174XenoPort Inc (NASDAQ: XNPT) shares moved up 67.16% to $10.66 at 10:12 am. The volume of XNPT shares traded was 4112% higher than normal. GlaxoSmithKline Plc (NYSE: GSK) and XNPT received approval from the US Food and Drug Administration (FDA) for the drug Horizant. Bed Bath & Beyond Inc (...
-
Pre-Market Top Percentage Gainers and Losers (XNPT, GSK, ZAGG, LOGI, BBBY, PRXL, BLUD, INHX, PWER, INTC, TZOO, KERX)
Thursday, April 7, 2011 - 9:11am | 313Best 1) XenoPort (NASDAQ: XNPT): Posting a huge pre-market gain of 68.61% to $10.77. An FDA approval for its drug, along with partner GlaxoSmithKline (NYSE: GSK), has shares skyrocketing. 2) ZAGG (NASDAQ: ZAGG): Trading up 13% to $9.28. Investors are responding well to an agreement with Logitech...
-
LifeTech Capital Comments On Merck Acquisition (MRK, ISPH)
Thursday, April 7, 2011 - 8:42am | 131On April 5, 2010, Merck (NYSE: MRK) announced that they are acquiring Inspire Pharmaceuticals (NASDAQ: ISPH) for approximately $430 million, LifeTech Capital reports. “Merck stated goal is to strengthen their ophthalmic portfolio with Inspire's AZASITE (azithromycin ophthalmic solution) for the...
-
Morgan Keegan Raises PT On COO
Thursday, April 7, 2011 - 8:36am | 92Morgan Keegan, after meeting with management at The Cooper Companies (NYSE: COO) has reiterated its Outperform rating and has upped its price target from $73 to $80. Morgan Keegan states, “The key take-aways from our meeting include: (1) management articulated a plan to drive operating margin to...
-
Morgan Keegan Raises PT On COO
Thursday, April 7, 2011 - 8:36am | 92Morgan Keegan, after meeting with management at The Cooper Companies (NYSE: COO) has reiterated its Outperform rating and has upped its price target from $73 to $80. Morgan Keegan states, “The key take-aways from our meeting include: (1) management articulated a plan to drive operating margin to...
-
Morgan Keegan Raises PT On COO
Thursday, April 7, 2011 - 8:36am | 92Morgan Keegan, after meeting with management at The Cooper Companies (NYSE: COO) has reiterated its Outperform rating and has upped its price target from $73 to $80. Morgan Keegan states, “The key take-aways from our meeting include: (1) management articulated a plan to drive operating margin to...
-
Benzinga's Top Pre-Market NASDAQ Gainers (XNPT, ZAGG, BBBY, BLUD)
Thursday, April 7, 2011 - 8:16am | 135XenoPort Inc (NASDAQ: XNPT) added 70.85% to $10.90 in the pre-market session. GlaxoSmithKline Plc (NYSE: GSK) and XNPT received approval from the US Food and Drug Administration (FDA) for Horizant. ZAGG Incorporated (NASDAQ: ZAGG) moved up 11.66% to $9.10 in the pre-market session. ZAGG signed an...
-
Morgan Keegan Raises PT On The Cooper Companies To $80
Thursday, April 7, 2011 - 6:55am | 28Morgan Keegan has raised the price target on The Cooper Companies (NYSE: COO) from $74 to $80 and maintains its Outperfrom rating.
-
US Stock Futures Flat As Investors Await Economic Data, ECB Meeting; Bed Bath & Beyond Shares Rise In Pre-Market Trading
Thursday, April 7, 2011 - 6:33am | 498US stock futures are flat this morning, as investors are awaiting economic data and the European Central Bank (ECB) interest-rate meeting. Several retailers are also scheduled to report same-store sales. Futures for the Dow Jones Industrial Average lost 2 points to 12,355.00, while those for the S...
-
Stocks To Watch For April 7 (BBBY, STZ, BLUD, RAD, RT)
Thursday, April 7, 2011 - 12:16am | 356Some of the stocks that may grab investor focus today are: Bed Bath & Beyond Inc (NASDAQ: BBBY) reported its Q4 earnings at $283.5 million, or $1.12 per share, up from $226 million, or $0.86 per share, in the year-ago period. The company's sales increased around 12% to $2.50 billion. Sales at...
-
Immucor Jumps After Earnings (BLUD)
Wednesday, April 6, 2011 - 5:04pm | 159Immucor (NASDAQ: BLUD) released its Q3 earnings results after the closing bell on Wednesday. The company reported net income of $22.7 million, or $0.32 per share, compared to $20.1 million, or $0.28 per share, in last year's fourth quarter. This came in ahead of Street EPS consensus of $0.27....